Skip to main content
    D

    DaVita HealthCare Partners Inc (DVA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $174.14
    -0.42 (-0.24%)

    Market Cap: $10.98B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    DaVita HealthCare Partners Inc (DVA) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    DaVita HealthCare Partners (DVA) trades at 12.3x trailing earnings and 0.8x sales. Its P/E of 12.3x is below its 5-year median of 13.8x. Its forward P/E is 9.5x. The median P/E across 12 similar companies is 22.1x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 29.5% higher over the next year. Its free cash flow yield is 11.6%.

    MultipleValue
    P/E (trailing)12.3x
    Forward P/E9.5x
    Price to sales0.8x
    EV/EBITDA7.6x
    Price to FCF8.6x
    EV/FCF16.5x
    PEG0.4
    FCF yield11.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 16.3% below 14.7x and its P/S is 20.0% below 1.0x.

    MultipleCurrent5-year median10-year median
    P/E12.3x13.8x14.7x
    P/S0.8x0.9x1.0x
    P/BN/AN/A4.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 103 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 10.5x in 2025 to 21.0x in 2017. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$113.6110.5x0.7x8.6x
    2024$149.5515.3x1.0x6.1x
    2023$104.7612.5x0.8x3.5x
    2022$74.6712.5x0.6x3.1x
    2021$113.7612.5x1.0x5.0x
    2020$117.4016.2x1.2x4.7x
    2019$75.0313.6x1.0x2.8x
    2018$51.4614.5x0.8x1.7x
    2017$72.2521.0x1.2x2.3x
    2016$64.2016.6x1.2x2.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DVA

    What is DVA's forward P/E ratio?

    DaVita HealthCare Partners has a forward P/E ratio of 9.5x.

    Is DVA stock overvalued?

    GNG's valuation label for DVA is Undervalued. Its P/E of 12.3x compares with a median of 22.1x across 12 similar companies.

    What is DVA's price to sales ratio?

    DaVita HealthCare Partners has a price to sales ratio of 0.8x.

    What is DaVita HealthCare Partners's average P/E ratio over 5 years?

    DaVita HealthCare Partners's median P/E over the last 5 years is 13.8x, from 60 month-end values through Oct 2026.

    What is DVA's PEG ratio?

    DaVita HealthCare Partners has a PEG ratio of 0.4.